Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 10,857

Document Document Title
WO/2011/012247A1
Described are 2-(3-alkylthiobenzoyl)cyclohexanediones of the general formula (I) as herbicides. X, Y, R1 to R8 in this formula (I) stand for radicals such as hydrogen or organic radicals such as alkyl and alkoxy.  
WO/2011/008543A2
Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated...  
WO/2011/007146A1
Compounds of formula (I) are suitable for use as herbicides: wherein R is methyl, ethyl, vinyl, ethynyl or cyclopropyl, R1 is hydrogen, C1-C6alkyl, C1-C6haloalkyl, C3-C7cycloalkyl, C1-C6alkoxy, C1-C6haloalkoxy, vinyl, propenyl, ethynyl, ...  
WO/2011/005127A1
The present invention relates to a new stable crystalline polymorph of 2-(2-chloro-4-mesyl-benzoyl)-cyclohexane-1,3-dione and to a process for preparing the same. More particularly, it relates to compositions having said polymorph for co...  
WO/2010/107807A3
The present invention is directed to a compound of 2-N halo-4-methylsulfonyl-butyric acid, such as 2-N chloro-4-methylsulfonyl-butyric acid, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed...  
WO/2010/148488A1
The present invention relates to compounds capable of inhibiting and/or decreasing the activity of one or more cathepsins, thereby treating and/or preventing various disease states associated with one or more cysteine proteases including...  
WO/2010/144959A1
The present invention relates to analogues of anti-fibrotic agents having the formula (I) with the substituents as described within the specification. The present invention also relates to methods for their preparation.  
WO/2010/147228A1
A pattern forming method, including: (i) forming a film from a chemical amplification resist composition; (ii) exposing the film, so as to form an exposed film; and (iii) developing the exposed film by using a developer containing an org...  
WO/2010/142650A1
The invention relates to compounds of formula (I) wherein A1, R1, R2, R3, R4 and R5 are defined in the description and in the claims, which are preferential inhibitors of the cysteine protease cathepsin, in particular of the cysteine pro...  
WO/2010/143578A1
Provided are a process for preparing alkyl sulfone compounds easily and safely in a high yield, and alkyl sulfone compounds. Specifically provided is a process for the preparation of alkyl sulfone compounds of general formula (2) which c...  
WO/2010/139090A1
N-Phenyl dichloroacetamide and their derivatives which belong to pharmaceutical chemistry and organic synthesis fields are provided. These compounds have the structures of general formula I, in which N-{3-chloro-4-[(trifluoromethyl)sulfo...  
WO/2010/137620A1
Disclosed is a phenoxyethylamine derivative having an excellent selective α1D adrenergic receptor antagonistic activity. Specifically disclosed is a compound represented by formula (I) [wherein each symbol is as defined in the descripti...  
WO/2010/103297A3
There is provided compounds of formula (I), wherein Y, ring A1 D1, D2a, D2b, D3, L1, Y1, L3 and Y3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of dise...  
WO/2010/130124A1
A new preparation of aliphatic amines with sulphonyl group and their salts, using sulfonates with sulphonyl group as raw material and ammonia or amine as substituent reagent reacting with the raw material to obtain the product. A new kin...  
WO/2010/126349A1
The object of the present invention is to demonstrate that it is possible to prepare a soluble pharmaceutical form of N,N'-diaminodiphenyl sulphone that can be used to produce an optimum drug for use against cerebral infarction, epilepsy...  
WO/2010/123139A1
Disclosed is a long-chain fatty acid elongase (Elovl6) inhibitor, which is characterized by comprising at least one of a compound represented by formula (I), a pharmaceutically acceptable salt of the compound, and a solvate of the compou...  
WO/2010/123071A1
Disclosed is a dye composition which has high clarity and color developability, while exhibiting excellent fastnesses such as heat resistance, wet heat resistance and water resistance. Specifically disclosed are a triarylmethane compound...  
WO/2010/122968A1
Disclosed is a compound useful as an anti-obesity agent. Studies have been made on compounds which have a DGAT1 inhibitory activity and are therefore promising active ingredients for pharmaceutical compositions for treating obesity, type...  
WO/2010/115945A1
The present invention relates to a compound of the general formula (I) where: X = S, SO or SO2; and one of the radicals R1 and R2 is a hydrogen atom and the other is a radical: a C1 to C18 linear or branched alkyl, optionally substituted...  
WO/2010/068371A3
Embodiments of this disclosure, among others, encompass methods for generating alkenes under mild thermolytic conditions that can provide almost total conversion of a precursor compound to an alkene without isomerization or the need to c...  
WO/2010/117475A1
A fiber sizing formulation includes (1) a nanoparticle (NP)solution that includes a dispersion of transition metal nanoparticles (NPs) in a solvent and (2) a first fiber sizing agent. The NPs disperse throughout the first fiber sizing ag...  
WO/2010/116342A2
The present invention concerns compounds of general Formula (I) : method of preparation and uses thereof.  
WO/2010/107807A2
The present invention is directed to a compound of 2-N halo-4-methylsulfonyl-butyric acid, such as 2-N chloro-4-methylsulfonyl-butyric acid, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed...  
WO/2010/059004A3
The present invention relates to a chemical inhibitor of p53-Snail binding and to a pharmaceutical composition for treating cancer diseases containing the same as its active ingredient. The chemical inhibitor of p53-Snail binding induces...  
WO/2010/074332A3
There is provided a sulfur-containing compound having a controlling effect on arthropod pests represented by the formula (I): wherein m represents 1, 2 or 3; n represents 0, 1 or 2; A represents an optionally substituted C2-C10 fluoroalk...  
WO/2010/094659A1
The invention relates to the use of compounds of formula (I), wherein the substituents are described in the description and claims, for the preparation of medicaments for the treatment of psychoses, dysfunction in memory and learning, sc...  
WO/2010/092180A1
The present invention relates to aminotetraline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline derivatives, and the use of s...  
WO/2010/090305A1
Disclosed is an excellent agent for treatment or prevention of dementia, schizophrenia and the like, which has a serotonin 5-HT5A receptor modulating activity. An acylguanidine derivative represented by formula (I), wherein guanidine is ...  
WO/2010/090954A1
The present invention is directed to a novel trifluoromethylsulfonamide derivative which inhibits the processing of APP by the putative γ-secretase and thus is useful in the treatment or prevention of Alzheimer's disease. This compound ...  
WO/2006/013193A8
Described herein are derivatives of arylsulfonamido-substituted hydroxamic acid of formula (I) having good solubility in water and inhibitory activity of matrix metalloproteinases, useful for the preparation of pharmaceutical composition...  
WO/2010/056877A3
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is dir...  
WO/2010/084975A1
Disclosed is a method for producing a conjugated aromatic compound, which is characterized in that an aromatic compound (A) represented by formula (1) is reacted with another aromatic compound (A) which has the same structure as the arom...  
WO/2010/049946A3
The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta (TR-Beta). Further, the present invention relates to processes ...  
WO/2010/084976A1
Disclosed is a method for manufacturing a conjugated aromatic compound, which is characterized in that an aromatic compound (A), wherein one or two leaving groups selected from a group comprised of an iodine atom, bromine atom and chlori...  
WO/2010/059004A9
The present invention relates to a chemical inhibitor of p53-Snail binding and to a pharmaceutical composition for treating cancer diseases containing the same as its active ingredient. The chemical inhibitor of p53-Snail binding induces...  
WO/2010/056527A3
The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the co...  
WO/2010/074332A2
There is provided a sulfur-containing compound having a controlling effect on arthropod pests represented by the formula (I): wherein m represents 1, 2 or 3; n represents 0, 1 or 2; A represents an optionally substituted C2-C10 fluoroalk...  
WO/2010/069150A1
The para-hydrobenzene acrylic acid derivatives of formula (I) and pharmaceutically acceptable salts, preparation methods, their pharmaceutical compositions and uses for preparing drugs for treating and preventing inflammations or disease...  
WO/2010/069778A1
Methods for producing a compound of formula (k1) or (k2) by reducing a dihydronapthalene amide compound of formula (i); with hydrogen gas in the presence of a ruthenium catalyst of formula (j1) or (j2); Ru(Z)2(L) = (j1), Ru(E)(E')(L)(D) ...  
WO/2010/028088A3
Provided are sulphur-linked compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.  
WO/2010/068371A2
Embodiments of this disclosure, among others, encompass methods for generating alkenes under mild thermolytic conditions that can provide almost total conversion of a precursor compound to an alkene without isomerization or the need to c...  
WO/2010/063767A1
The invention relates to compounds of the general formula (I) wherein the variable have the meanings as indicated in the claims, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They...  
WO/2010/059004A2
The present invention relates to a chemical inhibitor of p53-Snail binding and to a pharmaceutical composition for treating cancer diseases containing the same as its active ingredient. The chemical inhibitor of p53-Snail binding induces...  
WO/2010/056877A2
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is dir...  
WO/2010/055911A1
A compound represented by formula (I) or a salt thereof, which is useful as an agent for treatment or prevention of various epileptic seizures, namely partial seizures and/or generalized seizures. (In the formula, R1, R2 and R3 may be th...  
WO/2010/056527A2
The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the co...  
WO/2010/055005A1
The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates...  
WO/2010/055004A1
The invention is concerned with the compounds of formula I, and pharmaceutically acceptable salts and esters thereof, wherein W, X, Y, and R1- R7 are defined in the detailed description and claims. In addition, the present invention rela...  
WO/2010/054565A1
The present invention provides the water-soluble prodrug of (R)-(-)-bicalutamide as follows of formula (I), its pharmaceutically acceptable salts, its preparation method and uses thereof. The compound of formula (I) is useful for treatme...  
WO/2010/055744A1
An aprotic polar solvent having a relatively low melting point and excellent thermal stability, which is chiefly useful as solvents for electrochemical devices and the like. Specifically disclosed is a sulfone compound represented by for...  

Matches 401 - 450 out of 10,857